Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q3)Sep 30, 2025 | (Q2)Jun 30, 2025 | (Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | -43.33%204M | 113.19%194M | 11.61%125M | -32.09%529M | -114.45%-34M | 25.15%360M | 91M | 112M | 779M | 235.34M |
| Net income from continuing operations | 52.46%93M | 9.09%96M | -21.43%88M | -28.51%316M | -48.73%55M | -31.47%61M | --88M | --112M | --442M | --107.27M |
| Operating gains losses | 0.00%-12M | 0.00%-13M | 8.33%-11M | -136.00%-118M | -512.88%-81M | 9.38%-12M | ---13M | ---12M | ---50M | ---13.22M |
| Depreciation and amortization | 4.92%64M | 1.61%63M | 1.64%62M | 0.82%246M | -1.63%62M | 1.12%61M | --62M | --61M | --244M | --63.02M |
| Asset impairment expenditure | --0 | ---- | ---- | --7M | --0 | --7M | ---- | ---- | --0 | --0 |
| Unrealized gains and losses of investment securities | 29.17%-17M | 42.31%-15M | 800.00%7M | -76.92%6M | 451.46%56M | -150.19%-24M | ---26M | ---1M | --26M | ---15.93M |
| Deferred tax | 22.39%82M | 183.33%20M | -20.00%4M | -11.94%59M | -12.42%11M | 550.52%67M | ---24M | --5M | --67M | --12.56M |
| Other non cashItems | -350.00%-5M | -75.00%2M | 700.00%6M | -61.54%5M | -188.60%-5M | -9.38%2M | --8M | ---1M | --13M | --5.64M |
| Change In working capital | -108.29%-15M | 235.29%23M | 30.56%-50M | -82.35%-62M | -352.63%-152M | 161.74%181M | ---17M | ---72M | ---34M | --60.17M |
| -Change in receivables | ---- | ---- | ---- | 140.24%101M | ---- | ---- | ---- | ---- | ---251M | ---- |
| -Change in inventory | ---- | ---- | ---- | -179.37%-50M | ---- | ---- | ---- | ---- | --63M | ---- |
| -Change in payables and accrued expense | ---- | ---- | ---- | 32.50%-81M | ---- | ---- | ---- | ---- | ---120M | ---- |
| -Change in other current assets | ---- | ---- | ---- | -111.68%-32M | ---- | ---- | ---- | ---- | --274M | ---- |
| Dividends received (cash flow from operating activities) | -17.65%14M | 38.46%18M | -5.00%19M | -1.41%70M | 26.39%20M | -22.97%17M | --13M | --20M | --71M | --15.82M |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | -43.33%204M | 113.19%194M | 11.61%125M | -32.09%529M | -114.45%-34M | 25.15%360M | --91M | --112M | --779M | --235.34M |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | 14.75%-52M | -520.00%-31M | -3,100.00%-32M | -229.03%-80M | -143.87%-13M | -4,045.87%-61M | -5M | -1M | 62M | 29.63M |
| Capital expenditure reported | 16.13%-52M | -70.00%-34M | -166.67%-32M | -229.73%-122M | -148.86%-28M | -666.15%-62M | ---20M | ---12M | ---37M | ---11.25M |
| Net other investing changes | ---- | -80.00%3M | ---- | -57.58%42M | -63.31%15M | -84.90%1M | --15M | --11M | --99M | --40.88M |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | 14.75%-52M | -520.00%-31M | -3,100.00%-32M | -229.03%-80M | -143.87%-13M | -4,045.87%-61M | ---5M | ---1M | --62M | --29.63M |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | -102.26%-103M | 60.90%-104M | -169.44%-100M | 46.79%-307M | -1,010.55%-4.73B | 3,086.65%4.55B | -266M | 144M | -577M | -426.19M |
| Net issuance payments of debt | --0 | ---- | ---- | 46.57%-187M | -1,096.78%-4.72B | 10,162.72%4.53B | ---- | ---- | ---350M | ---394.14M |
| Cash dividends paid | ---104M | ---104M | ---104M | ---- | ---- | --0 | --0 | --0 | ---- | ---- |
| Proceeds from stock option exercised by employees | --1M | --0 | --4M | --9M | --9M | --0 | --0 | --0 | --0 | ---- |
| Interest paid (cash flow from financing activities) | ---- | ---- | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- |
| Net other financing activities | ---- | ---- | ---- | 43.17%-129M | 60.28%-25M | -81.74%18M | ---266M | --144M | ---227M | ---62.94M |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | -102.26%-103M | 60.90%-104M | -169.44%-100M | 46.79%-307M | -1,010.55%-4.73B | 3,086.65%4.55B | ---266M | --144M | ---577M | ---426.19M |
| Net cash flow | ||||||||||
| Beginning cash position | 30.64%452M | -25.29%390M | 51.53%397M | 6,450.00%262M | 1,102.96%5.19B | --346M | --522M | --262M | --4M | --431.1M |
| Current changes in cash | -98.99%49M | 132.78%59M | -102.75%-7M | -46.21%142M | -2,864.91%-4.78B | 1,030.11%4.85B | ---180M | --255M | --264M | ---161.22M |
| Effect of exchange rate changes | --0 | -25.00%3M | --0 | -16.67%-7M | -9.66%-9M | -417.17%-7M | --4M | --5M | ---6M | ---8.21M |
| End cash Position | -90.34%501M | 30.64%452M | -25.29%390M | 51.53%397M | 51.53%397M | 1,102.96%5.19B | --346M | --522M | --262M | --262M |
| Free cash from | -48.99%152M | 125.35%160M | -7.00%93M | -45.15%407M | -127.67%-62M | 6.60%298M | --71M | --100M | --742M | --224.09M |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.